Brief: Kuros Biosciences Reports Says H1 Net Loss Per Share CHF 0.14
Aug 9 (Reuters) - Kuros Biosciences Ag KURN.S :
* KUROS BIOSCIENCES REPORTS RESULTS FOR FIRST HALF 2023
* H1 NET LOSS PER SHARE CHF 0.14
* H1 REVENUES FROM PRODUCT SALES AMOUNTED TO CHF 12.9
MILLION
(FIRST HALF 2022: CHF 5.7 MILLION)
Source text for Eikon: ID:nEQ7G1JmXa
Further company coverage: KURN.S
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kuros Biosciences AG
See all newsSwitzerland's Kuros Biosciences swing to H1 profit as revenue jumps
Brief: Kuros Biosciences H1 Gross Profit USD 79.965 Million
Europe Research Roundup: Avanza Bank, Forvia, Novonesis
Switzerland's Kuros Biosciences 2025 total medical device revenue rises, helped by MagnetOs growth
Brief: Kuros Biosciences FY Net Income USD 2.462 Million